Entity

Time filter

Source Type


Dadkhah E.,Mashhad University of Medical Sciences | Dadkhah E.,George Mason University | Naseh H.,Omid Hospital | Farshchian M.,Mashhad University of Medical Sciences | And 10 more authors.
Archives of Iranian Medicine | Year: 2013

Background: Esophageal squamous cell carcinoma (ESCC) is the second-most frequently diagnosed cancer in Northeast Iran, often diagnosed in advanced stages. No standard early diagnostic guideline has been proposed to date and current therapeutic modalities are not effective. Detection of tumor-specific biomarkers, which is the goal of this study, could prove useful in the diagnosis of ESCC. Methods: To better understand the gene expression profile of ESCC, we analyzed tumor samples and corresponding adjacent normal tissue from ESCC patients by Chemiluminescent Human Cancer GEArrays. Candidate genes were verified by real-time PCR. Results: Out of 440 cancer-related genes included in the array, 71 were overexpressed compared to normal tissue, with significant differences in 11 genes. There were 108 genes underexpressed, with significant differences in 5 genes. Until now, the AP2M1, FTL, UBE2L6, HLA-C, and HSPA8 overexpressed genes and XRCC5, TP53I3 and RAP1A underexpressed genes were not reported in ESCC. We chose the MMP2, HLA-G, and XRCC5 markers from 58 Iranian ESCC patients to verify the expression validity by real-time PCR. The microarray results were confirmed with two-tailed significance levels of P = 0.003 (MMP2), P = 0.000 (HLA-G) and P = 0.002(XRCC5). Analysis performed for the candidate genes using GNCpro online software highlighted two pathways, an immuno-modulatory response and DNA replication and repair. We successfully performed and validated Chemiluminescent GEArray gene expression profiling in ESCC. Several biomarkers that might be related to tumorigenesis in ESCC were identified. Conclusion: Immuno-modulatory and DNA repair pathways could be used as targets to locate specific diagnostic, prognostic, and therapeutic biomarkers for ESCC. Source


Nakhaei Moghaddam M.,Islamic Azad University at Mashhad | Hashemi Beidokhti M.,Islamic Azad University at Science and Research of Fars | Amel Jamehdar S.,Mashhad University of Medical Sciences | Ghahraman M.,Medical Genetic Research Center
Iranian Journal of Basic Medical Sciences | Year: 2014

Objective(s): blaCTX-M and blaPER are two genes that encode class A extended-spectrum β-lactamases (ESBLs) and can be responsible for therapeutic problems. This study was carried out to evaluate the molecular properties of these genes in clinical isolates of Enterobacteriaceae by polymerase chain reaction (PCR), restriction digestion and sequencing. Materials and Methods: During six months, starting from January 2012, one hundred clinical isolates of Enterobacteriaceae were collected from urinary samples. The ESBL-producing isolates were detected by phenotypic confirmation test. After plasmid extraction, blaPER and blaCTX-M genes were detected using PCR by specific primers. The blaCTX-M PCR products were digested with Taq1, and two of the blaCTX-M genes were sequenced. Results: Phenotypic tests showed that 27 (27%) isolates were ESBL producers with the highest frequency for Klebsiella pneumoniae (47.4%) and Escherichia coli (17.9%). Twenty six (26%) of Enterobacteriaceae isolates harbored the blaCTX-M gene, and none of them had blaPER. The restriction analysis of PCR products showed that all blaCTX-M amplified products had the same patterns. Both sequenced bacteria were CTX-M-15 type ESBL carriers. Conclusion: The results of this study showed the blaCTX-M-15 gene in Enterobacteriaceae isolates for the first time in Mashhad, Iran. High degrees of associated resistance to co-trimoxazole and gentamicin were found in ESBL producers. Therefore, an integrated and regular management of antibiotic prescription need to be trained in our society. Source


Stepanova A.A.,Medical Genetic Research Center | Krasovsky S.A.,Research Institute of Pulmonology | Polyakov A.V.,Medical Genetic Research Center
Russian Journal of Genetics | Year: 2016

A study of Russian cystic fibrosis (CF) patient DNA was conducted to assess the incidence frequency of 19 mutations, namely CFTRdele2,3(21kb), F508del, I507del, 1677delTA, 2143delT, 2184insA, 394delTT, 3821delT, L138ins, 604insA, 3944delGT, G542X, W1282X, N1303K, R334W, and 3849 + 10kbC > T, S1196X, 621 + 1g > t, and E92K of the CFTR gene. We also sought to determine the estimated CF frequency in Russian Federation. In addition, we determined the total information content of the approach for 19 common mutations registration in the CFTR gene, 84.6%, and the allelic frequencies of the examined mutations: three mutations were observed with a frequency exceeding 5% (F508del, 53.98%, E92K, 6.47%, CFTRdele2,3(21kb), 5.35%); other mutations were observed with frequencies ranging from 0.13 to 3.0%. The CF population carrier frequency was 1 in 38 subjects, while the predicted CF frequency was 1 in 5776 newborns. © 2016, Pleiades Publishing, Inc. Source


Baskova I.P.,Moscow State University | Alekseeva A.Yu.,Moscow State University | Kostyuk S.V.,Medical Genetic Research Center | Neverova M.E.,Medical Genetic Research Center | And 2 more authors.
Biomeditsinskaya Khimiya | Year: 2012

The medicinal leech salivary cell secretion (SCS) may stimulate NO-production in cultures of human endothelium cells (HUVEC) and rat cardiomiocytes (RCM). This effect was detected using a NO specific reagent, - the complex Cu2+ with a fluorescein derivative (Cu-F1). NO had also been detected in the cells by fluorescent electronic microscopy and determined quantitatively in the cells and in culture fluid by the fluorescence method. SCS stimulated NO synthesis in HUVEC cells (but not in RCM) is accompanied by NO release into intercellular space. Localization of NO synthesis centers is presented and it is shown that the increase in NO levels during the SCS action on HUVEC and RCM is associated with the increase in the activity of eNOS/nNOS, but not iNOS. In endothelial cells SCS activates nitrosylation processes, assessed by the increase of nitrite-ions in the culture medium. It is therefore important to use Cu-F1, other than Griss-reagent, during the first hour of analysis of NO synthesis. The NO-depended mechanism of SCS action on endothelial cells might be a factor in providing of its positive action in hirudotheraphy. Source


Baskova I.P.,Moscow State University | Alekseeva A.Y.,Moscow State University | Kostyuk S.V.,Medical Genetic Research Center | Neverova M.E.,Medical Genetic Research Center | And 2 more authors.
Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | Year: 2013

Using a novel NO-specific reagent, the complex of Cu2+ with a fluorescein derivative (Cu-FL), stimulation of NO production by the medicinal leech salivary cell secretion (SCS) has been demonstrated for the first time in cultures of human endothelial cells (HUVEC) and rat cardiomyocytes (RCM). NO was detected in the cells by fluorescent electronic microscopy and determined quantitatively in the cells and in the culture fluid by the fluorescence method. SCSstimulated NO synthesis in HUVEC but not in RCM cells was accompanied by NO release into the intercellular space thus determining its subsequent distribution. Localization of intracellular NO synthesis centers is presented and it is shown that the increase in NO levels during the SCS action on HUVEC and RCM is associated with the increase in the activity of eNOS/nNOS, but not iNOS. In the endothelial cells SCS-activated nitrosylation processes, estimated by the increase of nitrite-ion content in the culture medium. It is therefore important to use Cu-FL, rather than Griss-reagent, during the first hour of analysis of NO synthesis. It is possible that the NO-depended mechanism of the SCS action on endothelial cells may be a factor responsible for the positive effect of SCS during hirudotheraphy. © 2013 Pleiades Publishing, Ltd. Source

Discover hidden collaborations